Yunfeng Capital
Alibaba confirms Hong Kong IPO plan for logistics unit
Alibaba Group’s logistics unit has filed for an IPO in Hong Kong, potentially creating liquidity events for private equity backers such as Yunfeng Capital, Primavera Capital Group, and Princeville Global, as well as for GIC, Temasek Holdings, and Khazanah...
DEG leads round for Indonesian mRNA vaccine developer
German development finance organisation DEG has contributed USD 8m as the lead investor in a new funding round for Etana Biotechnologies Indonesia, supported by Yunfeng Capital, HighLight Capital, and East Ventures.
China's Giant Biogene trades up after $70m Hong Kong IPO
Giant Biogene, a China-based producer of skin treatments that use bioactive ingredients, gained nearly 10% on debut following a HKD 549.4m (USD 70m) Hong Kong IPO.
Korea's Gentle Monster backs China AR player Nreal
Nreal, a Chinese manufacturer of augmented reality (AR) glasses that resemble normal sunglasses, has received USD15m from South Korean eyewear brand Gentle Monster.
China biotech player Sironax raises $200m Series B
Gaorong Capital and Yunfeng Capital have led a USD 200m Series B round for China’s Sironax, a drug developer targeting age-related degenerative diseases.
AstraZeneca-CICC fund backs China gene sequencer
Axbio, a China-based provider of gene sequencing and diagnostic systems, has raised nearly USD 100m in Series B funding led by AstraZeneca-CICC Healthcare Industrial Fund and Yunfeng Capital.
Alibaba leads Series C extension for China AR start-up Nreal
Nreal, a Chinese manufacturer of augmented reality (AR) glasses that resemble normal sunglasses, has raised an extended Series C of USD 60m led by Alibaba Group.
NetEase music spinout completes $449m Hong Kong IPO
Cloud Village, a music streaming business controlled by Chinese internet giant NetEase and backed by several private equity investors, has raised HK$3.5 billion ($449 million) through a Hong Kong IPO.
China's Momenta adds $500m to Series C round
Strategic and financial investors have put another $500 million into Chinese autonomous driving technology developer Momenta, endorsing the company's two-legged approach to commercialization
China vacuum cleaner brand Dreame raises $563m
Dreame, a Beijing-headquartered vacuum cleaner maker backed by smart phone and consumer electronics giant Xiaomi, has raised RMB3.6 billion ($563 million) in Series C funding.
China flying vehicle developer HT Aero raises $500m
HT Aero, an urban air mobility (UAM) company affiliated with Chinese electric vehicle manufacturer Xpeng, has raised a $500 million Series A round led by Xpeng, IDG Capital, and 5Y Capital.
Evergrande EV unit cancels listing, suffers cash crunch
Evergrande New Energy Vehicle (NEV) Group, the Hong Kong-listed electric vehicle unit of troubled Chinese real estate developer Evergrande has canceled a planned secondary listing on Shanghai's Star Market and warned investors of a cash shortage.
China AR glasses maker Nreal gets $100m Series C
Nreal, a Chinese manufacturer of advanced artificial reality (AR) glasses that resemble normal sunglasses, has raised a Series C of $100 million led by Nio Capital, Yunfeng Capital, and Hongtai Capital.
China vaccine developer Abogen raises $700m
Suzhou Abogen Biosciences, a Chinese vaccine developer targeting COVID-19, has raised $700 million in Series C funding featuring Temasek Holdings, Loyal Valley Capital, and Lilly Asia Ventures.
China education: Opportunity erased?
Private equity investors have pumped billions of dollars into Chinese online education platforms, notably in the K-12 space. A regulatory crackdown has left them wondering how they can get their money back
China's Manbang trades up after $1.57b US offering
Manbang, a China trucking business that claims to be the world’s largest digital freight platform, gained 13% on debut following a $1.57 billion IPO in the US.
Sequoia, Yunfeng lead $228m round for Chinese rice brand
Shiyuedaotian, a Chinese rice brand, has raised RMB1.45 billion ($228 million) in Series B funding led by Sequoia Capital China and Yunfeng Capital. CMC Group and Taihe Capital also took part, as did existing investor GenBridge Capital.
China trucking platform Manbang files for US IPO
Manbang, a China trucking business that claims to be the world’s largest digital freight platform, has filed for a US IPO. The company achieved a valuation of $12 billion in its most recent funding round six months ago.
Netease to spin out PE-backed music streaming business
Cloud Village, a music streaming business controlled by Chinese internet and gaming giant NetEase and backed by the likes of General Atlantic, Boyu Capital, and Yunfeng Capital, has filed for a Hong Kong IPO.
China snack maker Weilong raises $549m, pursues HK IPO
China’s leading spicy snack food company Weilong has raised a $549 million pre-IPO round at a valuation of $9.4 billion and filed for a Hong Kong IPO.
Deal focus: Xingyun’s trade flow proposition
Having built its business on imports into China, e-commerce enabler Xingyun now wants to take Chinese brands global as well. For HI Transformational Fund, it represents a compelling inflection point
China e-commerce enabler Xingyun raises $600m - update
China’s Xingyun Group, a digital supply chain provider for cross-border e-commerce, has raised $600 million in the second tranche of Series C round led by Yunfeng Capital, HI Transformational Fund, and Crescent Point.
PE-backed Brii Bioscience pursues Hong Kong listing
Brii Biosciences, a three-year-old Chinese biotech start-up that has raised approximately $415 million in private funding from the likes of Sequoia Capital China, Boyu Capital, and Yunfeng Capital, has filed for a Hong Kong IPO.
China mRNA vaccine provider Abogen raises $92m
Suzhou Abogen Biosciences, a Chinese mRNA vaccine provider, has raised RMB600 million ($92 million) led by PICC Capital - an investment unit under People’s Insurance Company of China - and state-backed SDIC Venture Capital.